APA (7th ed.) Citation

Yamashita, T., Higashi, M., Yamazaki, M., Imada, H., Takayanagi, N., Shimizu, T., . . . Momose, S. (2025). Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder Cancer. Pathology International, 75(4), 177. https://doi.org/10.1111/pin.70002

Chicago Style (17th ed.) Citation

Yamashita, Takahisa, et al. "Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder Cancer." Pathology International 75, no. 4 (2025): 177. https://doi.org/10.1111/pin.70002.

MLA (9th ed.) Citation

Yamashita, Takahisa, et al. "Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder Cancer." Pathology International, vol. 75, no. 4, 2025, p. 177, https://doi.org/10.1111/pin.70002.